# S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

> **NCT00109850** · PHASE2 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 22 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **DRUG:** cisplatin
- **DRUG:** irinotecan hydrochloride
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00109850
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** 2009-09
- **Final completion:** 2012-05
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Closed due to poor accrual
- **Last updated:** 2015-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109850, "S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00109850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*